Synthesis, in Vitro and in Vivo Anticancer Activity of Hybrids of 3- Hydroxy-indolin-2-one and 2,3-Dihydroquinolin-4(1H)-one

Author(s): Lei Zhang, Jing Wang, Wen-Yun Li, Juan Xia, Jing Gao, Qi-Zheng Yao

Journal Name: Letters in Drug Design & Discovery

Volume 12 , Issue 2 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


A series of hybrids of 3-hydroxy-indolin-2-one and 2,3-dihydroquinolin-4(1H) -one were synthesized and their anti-proliferative activities against two human cancer cell lines were initially evaluated. Compound 7g was selected for further study and demonstrated moderate anti-proliferative activities against four human cancer cell lines. Meanwhile, 7g had inhibitory effects on the growth of SGC-7901 cells in dosage-and time-dependent manners and the cancer cells appeared morphological changes. Moreover, 7g was more effective in the inhibition of xenografted tumor in vivo growth and mice treated with 7g showed more weight gain than 5-FU-treated mice over the treatment period, suggesting a lower toxic effect than 5-FU. After treatment with 7g, the tumor showed typical morphological changes as evaluated by H&E staining.

Keywords: 3-Hydroxy-indolin-2-one, 2, 3-Dihydroquinolin-4(1H)-one, anticancer, hybrid, isatin, synthesis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [117 - 123]
Pages: 7
DOI: 10.2174/1570180811666140909010017
Price: $65

Article Metrics

PDF: 25
PRC: 1